Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Abstract
Background Patients who have residual invasive breast cancer after receiving neoadjuvant chemotherapy plus human epidermal growth factor receptor 2 (HER2)–targeted therapy have a worse...
Paper Details
Title
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Published Date
Feb 14, 2019
Volume
380
Issue
7
Pages
617 - 628
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History